AGMT
  • Die AGMT
    • Über uns
    • Vorstand
    • Team
    • Partner
    • Karriere
    • Kontakt
  • Studien
    • Hodgkin Lymphom
      • HD 21
      • AERN
      • BRESELIBET
    • Non-Hodgkin Lymphom
      • DSHNHL_NIVEAU
      • ORACLE
      • Pola-R-ICE
    • Multiples Myelom
      • MM-4
    • Pankreaskarzinom
      • DIsCOvER
    • COVID-19
      • INSERM_DisCoVeRy
  • Register
    • AIHA Registry
    • aMYELOIDr
    • ARIADNE NIS
    • CLL-Register
    • COVID-19 Register
    • LungCA Register
    • MBC Register
    • NGS Register
    • PTCL Register
  • Veranstaltungen
    • AGMT Jahresmeeting
    • Breast Cancer Talk
    • GI Cancer Summit
  • Publikationen
  • News
    • News Übersicht
    • Newsletter
    • News Archiv
  • Kontakt
  • AAA
  • Login
  • de
    Languages
    • en English
    • de Deutsch
Banner Salzburg Breast Cancer Talk 2019

In order of appearanceThe Faculty

Prof. Dr. Richard Greil
Head of the IIIrd Medical Department, University Hospital Salzburg, Paracelsus Medical University, Salzburg Cancer Research Institute (SCRI), Cancer Cluster Salzburg (CCS), Salzburg, Austria
Prof. Peter Schmid FRCP MD PhD
Centre Lead, Centre for Experimental Cancer Medicine, Director, Breast Cancer, St Bartholomew, Hospital London, London, United Kingdom
Karen Willard-Gallo MD PhD
Head, Molecular Immunology Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium
Dr. Roberto Salgado
Department of Pathology, GZA-ZNA Antwerp, Belgium; Division of Research, Peter Mac Callum Cancer Center, Melbourne, Australia
Cecilia Garlanda PhD
Associate Professor of Clinical Pathology, Department of Biomedical Sciences, Humanitas University, Head of Laboratory of Experimental Immunopathology, Humanitas Research Hospital, Milan, Italy
Marie-Agnès Doucey PhD MER
Project Leader,Department of Oncology UNIL CHUV, Ludwig Institute for Cancer Research, Lausanne Branch, Lausanne, Switzerland
Maria Vittoria Dieci MD
Assistant Professor, Department of Surgery, Oncology and Gastroenterology, Istituto Oncologico Veneto IRCCS, Division of Medical Oncology 2, University of Padova, Padova, Italy
Prof. Richard Kennedy MD PhD
McClay Professor of Medical Oncology, Queen‘s University of Belfast, Global VP and Medical Director Almac Diagnostics
Chiara Pozzi PhD
Staff scientist, Lab. Mucosal Immunology and Microbiota, Humanitas Clinical and Research Center, Milan, Italy
Shom Goel B Med Sci MBBS FRACP PhD
Instructor in Medicine, Dana-Farber Cancer Institute, Boston MA, USA
Prof. Dr. Fritz Aberger
Molecular Cancer and Stem Cell Research, Lab Department of Molecular Biology, University of Salzburg, Cancer Cluster Salzburg (CCS), Salzburg, Austria
Dr. Gabriel Rinnerthaler
IIIrd Medical Department, University Hospital Salzburg, Paracelsus Medical University, Salzburg Cancer, Research Institute (SCRI), Cancer Cluster Salzburg (CCS), Salzburg, Austria
Marco Gerlinger MD FRCP
Medical Oncologist and Research Group Leader, Translational Oncogenomics Laboratory, Centre for Evolution and Cancer, Institute of Cancer Research, London, United Kingdom
Prof. Dr. Barbara Seliger
Director of the Institute for Medical Immunology, Martin Luther University, Medical Faculty, Halle, Germany
Dr. Simon P. Gampenrieder
IIIrd Medical Department, University Hospital Salzburg, Paracelsus Medical University, Salzburg Cancer Research Institute (SCRI), Cancer Cluster Salzburg (CCS), Salzburg, Austria
Dr. Mathilde Jalving
Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
Dr. Dominik Berzaczy
Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Vienna, Austria
Cornelia Quadt MD
Sr. Clinical Program Leader, Translational Clinical Oncology, Novartis Institute for Biomedical Research, Novartis Campus, Basel, Switzerland
Prof. Dr. Udo Gaipl
Head of Radiation Immunobiology, Universitätsklinikum Erlangen, Department of Radiation Oncology, Erlangen, Germany

Programme

Friday, 01. March 2019

13:30 – 13:35 Welcome and introduction
Richard Greil, Salzburg
13:35 – 14:00 Current evidence of immunotherapy in breast cancer
Regula Deurloo, Senior Scientist Group Lead, Roche, Basel (stand-in for Peter Schmid)


14:00 – 16:15 Adaptive Immunity
Chair: Richard Greil, Karen Willard-Gallo
Tertiary Lymphoid Structures (TLS)
Karen Willard-Gallo (Brussels)
Change of the immune infiltrate during treatment
Roberto Salgado (Brussels)
Cancer-related inflammation
Cecilia Garlanda (Milan)
TIE-2-expressing monocytes
Marie-Agnes Doucey (Lausanne)
Panel discussion


17:00 – 18:30 Influence on Immunogenicity
Chair: Richard D. Kennedy, Shom Goel
Influence on immunogenicity by DNA damage
Richard D. Kennedy (Belfast)
Influence on immunogenicity by the microbiota
Chiara Pozzi (Milan)
Influence on immunogenicity by targeting CDK4/6
Shom Goel (Boston MA)


Saturday, 02. March 2019

08:30 – 09:30 Heterogeneity & Immune Escape
Chair: Fritz Aberger, Gabriel Rinnerthaler
Neoantigene heterogeneity
Marco Gerlinger (London)
Immune escape in breast cancer
Barbara Seliger (Halle)


09:30 – 10:30 Imaging
Chair: Simon P. Gampenrieder, Mathilde Jalving
Imaging techniques in immuno-oncology
Dominik Berzaczy (Vienna)
iRECIST 1.1
Mathilde Jalving (Groningen, NL)


11:15 – 13:00 New Treatment Approaches
Chair: Richard Greil, Udo Gaipl
Targeting the adenosine pathway
Cornelia Quadt (Basel, Novartis)
Immunomodulation by radiotherapy
Udo Gaipl (Erlangen)
Panel discussion & Closing remarks
Richard Greil (Salzburg)


Accreditation by EACCME®

3rd SALZBURG BREAST CANCER TALK – Mastering translational Immuno-Oncology has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) for a maximum of 7 European CME credits (ECMEC®s).

Venue

Organisation

Prof. Dr. Richard Greil
Dr. Simon P. Gampenrieder
Dr. Gabriel Rinnerthaler

AGMT gemeinnützige GmbH

Salzburg Cancer Research Institute (SCRI) with Laboratory of Immunological and Molecular Cancer Research (SCRI-LIMCR)

Center for Clinical Cancer and Immunology Trials (SCRI-CCCIT)

in Kooperation mit
Cancer Cluster Salzburg | www.cancercluster-salzburg.at

endorsed by ECCO – European CanCer Organisation | www.ecco-org.eu

Photos

Gruppenfoto

Salzburg Breast Cancer Talk 2019

G. Rinnerthaler, C. Quadt, MA Doucey, C. Pozzi, MV Dieci, C. Garlanda, R. Salgado, K. Willard-Gallo, R. Greil, R. Derloo, M. Jalving, RD Kennedy, SP Gampenrieder
Richard Greil

Salzburg Breast Cancer Talk 2019

Richard Greil
Richard Greil

Salzburg Breast Cancer Talk 2019

Richard Greil
Regula Derloo

Salzburg Breast Cancer Talk 2019

Regula Derloo decided to stand in for Peter Schmid at short notice. Thanks again!
Regula Derloo

Salzburg Breast Cancer Talk 2019

Regula Derloo
Regula Derloo

Salzburg Breast Cancer Talk 2019

Regula Derloo
Audience at Salzburg Breast Cancer Talk 2019

Salzburg Breast Cancer Talk 2019

Audience at Salzburg Breast Cancer Talk 2019
Karen Willard-Gallo

Salzburg Breast Cancer Talk 2019

Karen Willard-Gallo
Karen Willard-Gallo

Salzburg Breast Cancer Talk 2019

Karen Willard-Gallo
Karen Willard-Gallo

Salzburg Breast Cancer Talk 2019

Karen Willard-Gallo
Roberto Salgado

Salzburg Breast Cancer Talk 2019

Roberto Salgado
Roberto Salgado

Salzburg Breast Cancer Talk 2019

Roberto Salgado
Roberto Salgado

Salzburg Breast Cancer Talk 2019

Roberto Salgado
Marie-Agnès Doucey

Salzburg Breast Cancer Talk 2019

Marie-Agnès Doucey
Marie-Agnès Doucey

Salzburg Breast Cancer Talk 2019

Marie-Agnès Doucey
Marie-Agnès Doucey

Salzburg Breast Cancer Talk 2019

Marie-Agnès Doucey
Cecilia Garlanda

Salzburg Breast Cancer Talk 2019

Cecilia Garlanda
Panel discussion

Salzburg Breast Cancer Talk 2019

Panel discussion: R.Greil, K. Willard-Gallo, R. Derloo, R. Salgado, MV Dieci, C. Garlanda, MA Doucey
Panel discussion

Salzburg Breast Cancer Talk 2019

Panel discussion: R.Greil, K. Willard-Gallo, R. Derloo, R. Salgado, MV Dieci, C. Garlanda, MA Doucey
Panel discussion

Salzburg Breast Cancer Talk 2019

Panel discussion: R.Greil, K. Willard-Gallo, R. Derloo, R. Salgado, MV Dieci, C. Garlanda, MA Doucey
Audience at Salzburg Breast Cancer Talk 2019

Salzburg Breast Cancer Talk 2019

Audience at Salzburg Breast Cancer Talk 2019
Audience at Salzburg Breast Cancer Talk 2019

Salzburg Breast Cancer Talk 2019

Audience at Salzburg Breast Cancer Talk 2019
Audience at Salzburg Breast Cancer Talk 2019

Salzburg Breast Cancer Talk 2019

Audience at Salzburg Breast Cancer Talk 2019
Audience at Salzburg Breast Cancer Talk 2019

Salzburg Breast Cancer Talk 2019

Audience at Salzburg Breast Cancer Talk 2019
Audience at Salzburg Breast Cancer Talk 2019

Salzburg Breast Cancer Talk 2019

Audience at Salzburg Breast Cancer Talk 2019
Salzburg Breast Cancer Talk 2019

Salzburg Breast Cancer Talk 2019

Salzburg Breast Cancer Talk 2019

Photos: Franz Neumayr

Video

News

26Feb
4th SALZBURG BREAST CANCER TALK

POSTPONED DUE TO SARS-CoV-2 Due to the current situation concerning the coronavirus epidemic and the resulting travel restrictions of even already planned speakers, we have decided to reschedule our event „Salzburg Breast Cancer Talk“ to October 2022....

18Mrz
3rd SALZBURG BREAST CANCER TALK 2019 wieder voller Erfolg!

Die Veranstaltung 3rd SALZBURG BREAST CANCER TALK, MASTERING TRANSLATIONAL IMMUNO-ONCOLOGY vom 01. bis 02.03.2019, im PITTER Event Center Salzburg war mit über 100 Teilnehmern wieder ein voller Erfolg. Die Vortragenden, alle auf ihrem Fachgebiet international renommierte Wissenschaftler, verstanden es eindrucksvoll, dem fachkundigen Publikum Einblicke in ihre Forschung am Puls der Zeit zu gewähren. Die Disskusionsrunden […]...

16Nov
3rd SALZBURG BREAST CANCER TALK

01.- 02.03.2019  Salzburg   —   MASTERING TRANSLATIONAL IMMUNO-ONCOLOGY...

Breast Cancer Talk
  • Veranstaltungen
    • Breast Cancer Talk – 2022
    • Program
    • Venue
    • Organisation
  • Past Events
    • Breast Cancer Talk – 2019
    • Breast Cancer Talk – 2018
    • News Archive
Arbeitsgemeinschaft medikamentöse Tumortherapie gemeinnützige GmbH
Firmensitz und Rechnungsadresse: Gentzgasse 60/21, 1180 Wien
Zweigstelle & Zustelladresse: Wolfsgartenweg 31, 5020 Salzburg
Firmenbuchnummer: FN 289548 g
UID-Nummer: ATU63467108
+43 662 640 44 12
+ 43 664 142 25 04
+43 662 640 44 14
office@agmt.at
Copyright © AGMT gemeinnützige GmbH
  • Impressum
  • Datenschutzerklärung
  • LinkedIn AGMT